Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Kezar Life Sciences (KZR) Leases (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Leases for 5 consecutive years, with $749000.0 as the latest value for Q4 2025.

  • For Q4 2025, Leases fell 60.29% year-over-year to $749000.0; the TTM value through Dec 2025 reached $749000.0, down 60.29%, while the annual FY2025 figure was $749000.0, 60.29% down from the prior year.
  • Leases hit $749000.0 in Q4 2025 for Kezar Life Sciences, down from $1.0 million in the prior quarter.
  • Across five years, Leases topped out at $9.7 million in Q4 2022 and bottomed at $749000.0 in Q4 2025.
  • Average Leases over 5 years is $3.7 million, with a median of $2.6 million recorded in 2021.
  • Year-over-year, Leases soared 268.25% in 2023 and then crashed 73.45% in 2024.
  • Kezar Life Sciences' Leases stood at $2.7 million in 2021, then skyrocketed by 258.92% to $9.7 million in 2022, then crashed by 50.95% to $4.8 million in 2023, then tumbled by 60.53% to $1.9 million in 2024, then crashed by 60.29% to $749000.0 in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $749000.0, $1.0 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.